Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness

BACKGROUND & AIMS: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces but does not eliminate the risk for hepatocellular carcinoma (HCC). The development of surveillance strategies for HCC after the sustained virologic response (SVR) is therefore warranted. We aimed...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JHEP Rep
Auteurs principaux: Dajti, Elton, Marasco, Giovanni, Ravaioli, Federico, Colecchia, Luigi, Ferrarese, Alberto, Festi, Davide, Colecchia, Antonio
Format: Artigo
Langue:Inglês
Publié: Elsevier 2021
Sujets:
Short Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165428/
https://ncbi.nlm.nih.gov/pubmed/34095798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100289
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires